Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer

Nature Genetics

Volumn 39, Issue 2, 2007, Pages 232-236

  Schlesinger, Yeshayahu ^a   Straussman, Ravid ^a   Keshet, Ilana ^a   Farkash, Shlomit ^a   Hecht, Merav ^a   Zimmerman, Joseph ^a   Eden, Eran ^b   Yakhini, Zohar ^b,c   Ben Shushan, Etti ^a   Reubinoff, Benjamin E ^a   Bergman, Yehudit ^a   Simon, Itamar ^a   Cedar, Howard ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c AGILENT TECHNOLOGIES   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; EMBRYONIC ECTODERM DEVELOPMENT PROTEIN; HISTONE H3; LYSINE;

ARTICLE; CANCER CELL; CANCER GENETICS; CELL DIFFERENTIATION; CELL TYPE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; HUMAN; HUMAN CELL; HUMAN TISSUE; MARKER GENE; METHYLATION; NUCLEOSOME; PRIORITY JOURNAL;

CACO-2 CELLS; CARRIER PROTEINS; CELLS, CULTURED; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; LYSINE; METHYLATION; METHYLTRANSFERASES; NEOPLASMS; VIRAL ENVELOPE PROTEINS;

EID: 33846649587     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1950     Document Type: Article

References (30)

1. Keshet, I. et al. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet. 38, 149-153 (2006).
2. Lee, T.I. et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125, 301-313 (2006).
3. Bracken, A.P., Dietrich, N., Pasini, D., Hansen, K.H. & Helin, K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20, 1123-1136 (2006).
4. Vire, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874 (2005).
5. Brandeis, M. et al. Sp1 elements protect a CpG island from de novo methylation. Nature 371, 435-438 (1994).
6. Gidekel, S. & Bergman, Y. A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J. Biol. Chem. 277, 34521-34530 (2002).
7. Lock, L.F., Takagi, N. & Martin, G.R. Methylation of the HPRT gene on the inactive X occurs after chromosome inactivation. Cell 48, 39-46 (1987).
8. Feldman, N. et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 8, 188-194 (2006).
9. Plath, K. et al. Role of histone H3 lysine 27 methylation in X inactivation. Science 300, 131-135 (2003).
10. Silva, J. et al. Establishment of histone H3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 polycomb group complexes. Dev. Cell 4, 481-495 (2003).
11. Cao, R. & Zhang, Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 14, 155-164 (2004).
12. Squazzo, S.L. et al. Suz12 binds to silenced regions of the genome in a cell-typespecific manner. Genome Res. 16, 890-900 (2006).
13. Zardo, G. et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat. Genet. 32, 453-458 (2002).
14. Rush, L.J. & Plass, C. Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. Anal. Biochem. 307, 191-201 (2002).
15. Alaminos, M., Davalos, V., Cheung, N.K., Gerald, W.L. & Esteller, M. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J. Natl. Cancer Inst. 96, 1208-1219 (2004).
16. Bestor, T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9, 2395-2402 (2000).
17. Di Croce, L. et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079-1082 (2002).
18. Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428 (2002).
19. Wong, D.J., Foster, S.A., Galloway, D.A. & Reid, B.J. Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M0 growth arrest. Mol. Cell. Biol. 19, 5642-5651 (1999).
20. Esteller, M. et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001-3007 (2001).
21. Boyer, L.A. et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349-353 (2006).
22. McGarvey, K.M. et al. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res. 66, 3541-3549 (2006).
23. De Marzo, A.M. et al. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59, 3855-3860 (1999).
24. Robertson, K.D. et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27, 2291-2298 (1999).
25. Feltus, F.A., Lee, E.K., Costello, J.F., Plass, C. & Vertino, P.M. Predicting aberrant CpG island methylation. Proc. Natl. Acad. Sci. USA 100, 12253-12258 (2003).
26. Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624-629 (2002).
27. Bracken, A.P. et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22, 5323-5335 (2003).
28. Nguyen, C. et al. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J. Natl. Cancer Inst. 93, 1465-1472 (2001).
29. Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A. & Bongso, A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404 (2000).
30. Cao, R. & Zhang, Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol. Cell 15, 57-67 (2004).